This week saw major advances in AI-driven healthcare tools across the globe. In the US, Pathway Assistant launched as a pediatric care guide using hospital data to help doctors treat 70 conditions. A new tool helps patients fight insurance denials using AI-written appeal letters, while hospitals use video AI to review surgeons' work during operations.

Doctors are getting mixed results with AI—some tools reduce hospital readmissions by 47% for opioid patients, but others show bias in treatment suggestions based on patients' backgrounds. The US government delayed new AI rules for Medicare, saying more study is needed.

In China, Fangzhou Inc. rolled out home healthcare AI that talks to families and manages chronic diseases. Their special training system tries to fix AI "hallucinations" (mistakes) in medical advice. Spanish company Neurologyca made face-scanning AI that spots strokes by detecting 100 emotions.

Surveys show 65% of healthcare workers think AI will make their jobs easier. New FDA-cleared tools include AI surgery guides and software that writes medical record summaries. However, only 25% of hospitals say they have enough money for strong cybersecurity on these new systems.

Experts warn that AI rules need input from doctors, tech companies, and patients to work safely. They highlight successes like AI reading X-rays faster than humans but caution that most hospitals still don't know if AI saves them money.